REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV itolizumab Trial: RESURRECT
收藏数据链接：
官方服务：
资源简介：
Datasets pertaining to the manuscript, Original Research, entitled “<strong>RE</strong>covery and <strong>SUR</strong>vival of patients with moderate to severe acute <strong>RE</strong>spiratory distress syndrome (ARDS) due to <strong>C</strong>OVID-19: a multicentre, single-arm, Phase IV Itolizumab <strong>T</strong>rial: <strong>RESURRECT</strong>” are submitted here.
提供机构：
Zenodo创建时间：
2023-01-23
